GeneScience 
Welcome,         Profile    Billing    Logout  
 14 Products   11 Diseases  14 Products   35 Trials   189 News 
37 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jintropin (recombinant human growth hormone) / GeneScience
ChiCTR2100048579: Efficacy and Safety of JINTROLONG for Transitional Growth Hormone Deficiency

Recruiting
4
31
 
polyethylene glycol recombinant human growth hormone injection
The Children's Hospital of Zhejiang University School of Medicine; The Children's Hospital of Zhejiang University School of Medicine, GeneScience Pharmaceuticals Co., Ltd. (GenSci)
Transitional Growth Hormone Deficiency
 
 
ChiCTR2100054613: Effects of early application of PEG-rhGH on neurodevelopment and cognitive function in children with Combined methylmalonic acidemia and homocystinuria

Not yet recruiting
4
60
 
PEG-rhGH ;None
Zhengzhou Children's Hospital; Zhengzhou Children's Hospital, GeneScience Pharmaceuticals Co., Ltd.
Methylmalonic acidemia
 
 
NCT05353192: A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia

Recruiting
4
38
RoW
Recombinant human growth hormone
GeneScience Pharmaceuticals Co., Ltd., Children's Hospital of Fudan University, Tongji Hospital, Children's Hospital of Nanjing Medical University, Jiangxi Province Children's Hospital, Chengdu Women's and Children's Central Hospital, Shandong Provincial Hospital, Shengjing Hospital, Shanghai Children's Hospital, Children's Hospital of The Capital Institute of Pediatrics, West China Second University Hospital, Sichuan University
Achondroplasia
02/25
02/25
NCT05144035: A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants

Recruiting
4
138
RoW
PEG-rhGH, jintrolong
Tongji Hospital, GeneScience Pharmaceuticals Co., Ltd.
Small for Gestational Age Infant, Growth Hormone Treatment, Cognitive Developmental Disorder
12/25
06/26
ChiCTR2400087245: A Study on the Efficacy and Safety of Pegylated Recombinant Human Growth Hormone (Jintrolong®) in Children with Idiopathic Short Stature

Not yet recruiting
4
100
 
0.25 mg/kg/week Jintrolong?; 0.2 mg/kg/week Jintrolong?; 0.3 mg/kg/week Jintrolong?
Children's Hospital,Zhejiang University School of Medicine; Children's Hospital,Zhejiang University School of Medicine, GeneScience Pharmaceuticals Co., Ltd ,Changchun
ISS
 
 
NCT06135168: A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations

Completed
1
60
RoW
PEG-rhGH with new preparation, PEG-rhGH with present preparation
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
11/23
03/24
NCT06135155: A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations

Completed
1
48
RoW
PEG-rhGH with new preparation, PEG-rhGH with present preparation
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
12/23
03/24
NCT06331026: A Bioequivalence Study of Two Different PEG-rhGH Preparations.

Completed
1
87
RoW
PEG-rhGH with new preparation (T), PEG-rhGH with present preparation (R)
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
07/24
08/24
NCT06385145: A Bioavailability Study of Two Different PEG-rhGH Preparations.

Completed
1
16
RoW
PEG-rhGH with new preparation (T), PEG-rhGH with present preparation (R)
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
07/24
03/25
NCT06797505: A Bioequivalence Study of Two Different PEG-rhGH Preparations

Active, not recruiting
1
87
RoW
PEG-rhGH with new preparation (T), PEG-rhGH with present preparation (T)
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
06/25
09/25
GenSci034-102, NCT06840691: A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations

Not yet recruiting
1
87
RoW
PEG-rhGH with new preparation (T), PEG-rhGH with present preparation (T)
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
05/25
09/25
NCT07016802: A Clinical Study of GenSci134 in Healthy Male Adults

Not yet recruiting
1
64
RoW
GenSci134, GenSci134 Placebo, Recombinant Human Growth Hormone Injection (Norditropin®)
Changchun GeneScience Pharmaceutical Co., Ltd.
Healthy Volunteers
04/26
04/26
Gensci032-401, NCT06722079: A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome

Completed
N/A
743
RoW
Changchun GeneScience Pharmaceutical Co., Ltd., Tongji Hospital
Turner Syndrome
06/23
06/23
ChiCTR2200055228: Efficacy and safety of polyethylene glycol recombinant human growth hormone in patients with nonalcoholic fatty liver disease (NAFLD): a randomized, double-blind, placebo-controlled clinical study

Recruiting
N/A
74
 
Polyethylene Glycol Recombinant Human Growth Hormone ;Polyethylene Glycol Recombinant Human Growth Hormone Blank Vehicle
Shanghai Tenth People's Hospital; Shanghai Tenth People's Hospital, Changchun GeneScience Pharmaceutical Co., Ltd.
Non-alcoholic fatty liver disease (NAFLD)
 
 
NCT05070234: Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature

Not yet recruiting
N/A
150
NA
Blood collection for genetic analysis
Chunxiu Gong, Shanghai Children's Hospital, Second Affiliated Hospital of Guangzhou Medical University, Shenzhen Children's Hospital, Tongji Hospital, The Children's Hospital of Zhejiang University School of Medicine, Chengdu Women's and Children's Central Hospital, West China Second University Hospital, Sichuan University, The First Affiliated Hospital with Nanjing Medical University, GeneScience Pharmaceuticals Co., Ltd.
Small for Gestational Age Infant, Silver-Russell Syndrome, Genetic Diseases, Inborn
08/22
08/22
pegylated somatropin (Gensci  004) / GeneScience
ChiCTR1800017144: A diverse response study of Pegylated Somatropin to treat growth hormone deficiency children

Recruiting
4
900
 
low dose versus high dose of Pegylated Somatropin
The Children's Hospital, Zhejiang University School of Medicine; The Children's Hospital, Zhejiang University School of Medicine, GeneScience Pharmaceutical Co.Ltd, self-financing
Growth hormone deficiency
 
 
ELEVATE, NCT06007417: A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency

Not yet recruiting
3
162
US
GenSci004, Genotropin
Changchun GeneScience Pharmaceutical Co., Ltd.
GHD
05/25
08/25
ESCALATE, NCT06024967: A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency

Not yet recruiting
3
180
NA
PEG-somatropin
Changchun GeneScience Pharmaceutical Co., Ltd.
GHD
05/25
09/25
NCT02375620: Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

Active, not recruiting
2
96
RoW
PEG-somatropin
Changchun GeneScience Pharmaceutical Co., Ltd., Shanxi Provincial Maternity and Children's Hospital, Children's Hospital of Fudan University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, The First Hospital of Jilin University, Hunan Children's Hospital, Tongji Hospital, Affiliated Hospital of Jiangnan University, Jiangxi Province Children's Hospital, Children's Hospital of The Capital Institute of Pediatrics
Short Stature Children Born Small for Gestational Age (SGA)
12/23
12/25
NCT03255694: A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

Active, not recruiting
2
360
RoW
PEG-somatropin, Polyethylene Glycol Recombinant Human Somatropin Injection
GeneScience Pharmaceuticals Co., Ltd., Tongji Hospital, The First Hospital of Jilin University, Affiliated Hospital of Jiangnan University, The First Affiliated Hospital with Nanjing Medical University, Shanghai Children's Hospital, The Children's Hospital of Zhejiang University School of Medicine, Children's Hospital of Fudan University
Dwarfism
06/30
06/30
ChiCTR2100045731: The Effect of Polyethylene Glycol Recombinant Human Somatropin Injection (Jintrolong) on Metabolism in Pituitary Stalk Interruption Syndrome(PSIS) Adult Subjects Concurrent with Non-alcoholic Fatty Liver Disease (NAFLD): A Randomized, Single-blind, Placebo-controlled Prospective Cohort Trial

Recruiting
N/A
72
 
Jintrolong ;Placebo
Peking Union Medical College Hospital; Peking Union Medical College Hospital, Changchun GenSci Pharmaceutical Company LTD
Pituitary Stalk Interruption Syndrome
 
 
Study of PEGylated Recombinant Human Growth Hormone (Jintrolong) in Pediatric Subjects With X-linked dominant hypophosphatemic rickets (XLH), ChiCTR2300068368: To explore the effect of PEGylated Recombinant Human Growth Hormone (Jintrolong) combined with conventional therapy on height and key indicators in the treatment of X-linked dominant hypophosphatemic rickets

Not yet recruiting
N/A
40
 
PEGylated Recombinant Human Growth Hormone (Jintrolong) combined with conventional therapy; conventional therapy
Shandong Provincial Hospital Affiliated to Shandong First Medical University; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Changchun Gensci Pharmaceutical Co., Ltd.
X-linked dominant hypophosphatemic rickets (XLH)
 
 
Camcevi 42 mg (leuprolide 6-month depot) / Foresee Pharma, Intas
NCT05493709: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Active, not recruiting
3
93
US, RoW
Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide
Foresee Pharmaceuticals Co., Ltd., QPS Holdings LLC, Changchun GeneScience Pharmaceutical Co., Ltd.
Puberty; Precocious, Central
11/25
06/26
Zeyzelf (rivastigmine twice weekly) / Luye Group
NCT05853341: Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)

Completed
1
48
Europe
RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h
Luye Pharma Group Ltd., SocraTec R&D GmbH, SocraMetrics GmbH
Healthy
07/23
07/23
genakumab (Gensci048) / GeneScience
NCT05983445: Safety & Efffficacy of Genakumab in Patients With Frequent Flares

Completed
3
313
RoW
genakumab, • Gensci048, placebo for Diprospan, placebo for genakumab, Diprospan
Changchun GeneScience Pharmaceutical Co., Ltd.
Acute Gout Arthritis
04/24
04/24
Gensci 048-202, NCT05936281: A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)

Completed
2
165
RoW
Genakumab for injection, Colchicine
Changchun GeneScience Pharmaceutical Co., Ltd., Huashan Hospital
Gout, Gout Initiating Urate-loweringUrate-lowering Therapy
01/24
01/24
Gensci 048-203, NCT05936268: Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare

Completed
2
106
RoW
Genakumab for injection, Colchicine
Changchun GeneScience Pharmaceutical Co., Ltd., Huashan Hospital
Acute Gout, Gout Flare
02/24
02/24
NCT06189495: A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Recruiting
2
30
RoW
GenSci048, GenSci048 placebo
Changchun GeneScience Pharmaceutical Co., Ltd., West China Hospital
Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
03/26
10/26
NCT05328531: Clinical Study of Genakumab for Injection in Patients With Acute Gout

Completed
1/2
121
RoW
Genakumab for Injection, Placebo for Genakumab for Injection
Changchun GeneScience Pharmaceutical Co., Ltd., Huashan Hospital, Hainan General Hospital, Linyi People's Hospital, The Second Affiliated Hospital of Chongqing Medical University, Changhai Hospital, The First Affiliated Hospital with Nanjing Medical University, Shengjing Hospital, Affiliated Hospital of Nantong University
Acute Gout
06/22
06/22
NCT05894148: Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults

Completed
1
24
RoW
Genakumab injection, placebo
Changchun GeneScience Pharmaceutical Co., Ltd., Affiliated Hospital of North Sichuan Medical College
Interstitial Lung Disease
11/23
11/23
NCT05441046: Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors

Recruiting
1
120
RoW
Genakumab, Tislelizumab
GeneScience Pharmaceuticals Co., Ltd.
Malignant Solid Tumors
06/24
03/25
NCT06451848: A Bioequivalence Study of Two Different Dosage Form of Genakumab

Completed
1
178
RoW
Genakumab Injection (T, Solution for injection), Genakumab for Injection (R, Powder for solution for injection)
Changchun GeneScience Pharmaceutical Co., Ltd.
Gouty Arthritis (GA)
11/24
01/25
NCT05925452: To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

Recruiting
N/A
221
RoW
GenaKumab
Changchun GeneScience Pharmaceutical Co., Ltd.
Active Systemic Juvenile Idiopathic Arthritis
03/28
06/28
gentulizumab / GeneScience
NCT05221385: Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma

Terminated
1
58
RoW
Gentulizumab
Changchun GeneScience Pharmaceutical Co., Ltd.
Solid Tumor, Non-Hodgkin Lymphoma
05/23
10/23
NCT05263271: Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Recruiting
1
58
RoW
Gentulizumab
GeneScience Pharmaceuticals Co., Ltd., Ruijin Hospital, Shanghai Tong Ren Hospital, First Affiliated Hospital of Zhejiang University
Acute Myelogenous Leukemia, Myelodysplastic Syndromes
07/24
07/24
gentuximab / GeneScience
NCT05919381: Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.

Recruiting
3
752
RoW
Gentuximab Injection, Gentuximab Injection Placebo
GeneScience Pharmaceuticals Co., Ltd.
Adenocarcinoma of Stomach
12/24
01/25
NCT05223595: A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC

Recruiting
1
42
RoW
Gentuximab, Almonertinib
GeneScience Pharmaceuticals Co., Ltd.
Metastatic Non-Small Cell Lung Cancer
09/23
01/24
Genfulin (molgramostim topical gel) / GeneScience
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jintropin (recombinant human growth hormone) / GeneScience
ChiCTR2100048579: Efficacy and Safety of JINTROLONG for Transitional Growth Hormone Deficiency

Recruiting
4
31
 
polyethylene glycol recombinant human growth hormone injection
The Children's Hospital of Zhejiang University School of Medicine; The Children's Hospital of Zhejiang University School of Medicine, GeneScience Pharmaceuticals Co., Ltd. (GenSci)
Transitional Growth Hormone Deficiency
 
 
ChiCTR2100054613: Effects of early application of PEG-rhGH on neurodevelopment and cognitive function in children with Combined methylmalonic acidemia and homocystinuria

Not yet recruiting
4
60
 
PEG-rhGH ;None
Zhengzhou Children's Hospital; Zhengzhou Children's Hospital, GeneScience Pharmaceuticals Co., Ltd.
Methylmalonic acidemia
 
 
NCT05353192: A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia

Recruiting
4
38
RoW
Recombinant human growth hormone
GeneScience Pharmaceuticals Co., Ltd., Children's Hospital of Fudan University, Tongji Hospital, Children's Hospital of Nanjing Medical University, Jiangxi Province Children's Hospital, Chengdu Women's and Children's Central Hospital, Shandong Provincial Hospital, Shengjing Hospital, Shanghai Children's Hospital, Children's Hospital of The Capital Institute of Pediatrics, West China Second University Hospital, Sichuan University
Achondroplasia
02/25
02/25
NCT05144035: A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants

Recruiting
4
138
RoW
PEG-rhGH, jintrolong
Tongji Hospital, GeneScience Pharmaceuticals Co., Ltd.
Small for Gestational Age Infant, Growth Hormone Treatment, Cognitive Developmental Disorder
12/25
06/26
ChiCTR2400087245: A Study on the Efficacy and Safety of Pegylated Recombinant Human Growth Hormone (Jintrolong®) in Children with Idiopathic Short Stature

Not yet recruiting
4
100
 
0.25 mg/kg/week Jintrolong?; 0.2 mg/kg/week Jintrolong?; 0.3 mg/kg/week Jintrolong?
Children's Hospital,Zhejiang University School of Medicine; Children's Hospital,Zhejiang University School of Medicine, GeneScience Pharmaceuticals Co., Ltd ,Changchun
ISS
 
 
NCT06135168: A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations

Completed
1
60
RoW
PEG-rhGH with new preparation, PEG-rhGH with present preparation
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
11/23
03/24
NCT06135155: A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations

Completed
1
48
RoW
PEG-rhGH with new preparation, PEG-rhGH with present preparation
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
12/23
03/24
NCT06331026: A Bioequivalence Study of Two Different PEG-rhGH Preparations.

Completed
1
87
RoW
PEG-rhGH with new preparation (T), PEG-rhGH with present preparation (R)
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
07/24
08/24
NCT06385145: A Bioavailability Study of Two Different PEG-rhGH Preparations.

Completed
1
16
RoW
PEG-rhGH with new preparation (T), PEG-rhGH with present preparation (R)
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
07/24
03/25
NCT06797505: A Bioequivalence Study of Two Different PEG-rhGH Preparations

Active, not recruiting
1
87
RoW
PEG-rhGH with new preparation (T), PEG-rhGH with present preparation (T)
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
06/25
09/25
GenSci034-102, NCT06840691: A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations

Not yet recruiting
1
87
RoW
PEG-rhGH with new preparation (T), PEG-rhGH with present preparation (T)
Changchun GeneScience Pharmaceutical Co., Ltd.
Pediatric Growth Hormone Deficiency (PGHD)
05/25
09/25
NCT07016802: A Clinical Study of GenSci134 in Healthy Male Adults

Not yet recruiting
1
64
RoW
GenSci134, GenSci134 Placebo, Recombinant Human Growth Hormone Injection (Norditropin®)
Changchun GeneScience Pharmaceutical Co., Ltd.
Healthy Volunteers
04/26
04/26
Gensci032-401, NCT06722079: A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome

Completed
N/A
743
RoW
Changchun GeneScience Pharmaceutical Co., Ltd., Tongji Hospital
Turner Syndrome
06/23
06/23
ChiCTR2200055228: Efficacy and safety of polyethylene glycol recombinant human growth hormone in patients with nonalcoholic fatty liver disease (NAFLD): a randomized, double-blind, placebo-controlled clinical study

Recruiting
N/A
74
 
Polyethylene Glycol Recombinant Human Growth Hormone ;Polyethylene Glycol Recombinant Human Growth Hormone Blank Vehicle
Shanghai Tenth People's Hospital; Shanghai Tenth People's Hospital, Changchun GeneScience Pharmaceutical Co., Ltd.
Non-alcoholic fatty liver disease (NAFLD)
 
 
NCT05070234: Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature

Not yet recruiting
N/A
150
NA
Blood collection for genetic analysis
Chunxiu Gong, Shanghai Children's Hospital, Second Affiliated Hospital of Guangzhou Medical University, Shenzhen Children's Hospital, Tongji Hospital, The Children's Hospital of Zhejiang University School of Medicine, Chengdu Women's and Children's Central Hospital, West China Second University Hospital, Sichuan University, The First Affiliated Hospital with Nanjing Medical University, GeneScience Pharmaceuticals Co., Ltd.
Small for Gestational Age Infant, Silver-Russell Syndrome, Genetic Diseases, Inborn
08/22
08/22
pegylated somatropin (Gensci  004) / GeneScience
ChiCTR1800017144: A diverse response study of Pegylated Somatropin to treat growth hormone deficiency children

Recruiting
4
900
 
low dose versus high dose of Pegylated Somatropin
The Children's Hospital, Zhejiang University School of Medicine; The Children's Hospital, Zhejiang University School of Medicine, GeneScience Pharmaceutical Co.Ltd, self-financing
Growth hormone deficiency
 
 
ELEVATE, NCT06007417: A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency

Not yet recruiting
3
162
US
GenSci004, Genotropin
Changchun GeneScience Pharmaceutical Co., Ltd.
GHD
05/25
08/25
ESCALATE, NCT06024967: A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency

Not yet recruiting
3
180
NA
PEG-somatropin
Changchun GeneScience Pharmaceutical Co., Ltd.
GHD
05/25
09/25
NCT02375620: Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

Active, not recruiting
2
96
RoW
PEG-somatropin
Changchun GeneScience Pharmaceutical Co., Ltd., Shanxi Provincial Maternity and Children's Hospital, Children's Hospital of Fudan University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, The First Hospital of Jilin University, Hunan Children's Hospital, Tongji Hospital, Affiliated Hospital of Jiangnan University, Jiangxi Province Children's Hospital, Children's Hospital of The Capital Institute of Pediatrics
Short Stature Children Born Small for Gestational Age (SGA)
12/23
12/25
NCT03255694: A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

Active, not recruiting
2
360
RoW
PEG-somatropin, Polyethylene Glycol Recombinant Human Somatropin Injection
GeneScience Pharmaceuticals Co., Ltd., Tongji Hospital, The First Hospital of Jilin University, Affiliated Hospital of Jiangnan University, The First Affiliated Hospital with Nanjing Medical University, Shanghai Children's Hospital, The Children's Hospital of Zhejiang University School of Medicine, Children's Hospital of Fudan University
Dwarfism
06/30
06/30
ChiCTR2100045731: The Effect of Polyethylene Glycol Recombinant Human Somatropin Injection (Jintrolong) on Metabolism in Pituitary Stalk Interruption Syndrome(PSIS) Adult Subjects Concurrent with Non-alcoholic Fatty Liver Disease (NAFLD): A Randomized, Single-blind, Placebo-controlled Prospective Cohort Trial

Recruiting
N/A
72
 
Jintrolong ;Placebo
Peking Union Medical College Hospital; Peking Union Medical College Hospital, Changchun GenSci Pharmaceutical Company LTD
Pituitary Stalk Interruption Syndrome
 
 
Study of PEGylated Recombinant Human Growth Hormone (Jintrolong) in Pediatric Subjects With X-linked dominant hypophosphatemic rickets (XLH), ChiCTR2300068368: To explore the effect of PEGylated Recombinant Human Growth Hormone (Jintrolong) combined with conventional therapy on height and key indicators in the treatment of X-linked dominant hypophosphatemic rickets

Not yet recruiting
N/A
40
 
PEGylated Recombinant Human Growth Hormone (Jintrolong) combined with conventional therapy; conventional therapy
Shandong Provincial Hospital Affiliated to Shandong First Medical University; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Changchun Gensci Pharmaceutical Co., Ltd.
X-linked dominant hypophosphatemic rickets (XLH)
 
 
Camcevi 42 mg (leuprolide 6-month depot) / Foresee Pharma, Intas
NCT05493709: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Active, not recruiting
3
93
US, RoW
Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide
Foresee Pharmaceuticals Co., Ltd., QPS Holdings LLC, Changchun GeneScience Pharmaceutical Co., Ltd.
Puberty; Precocious, Central
11/25
06/26
Zeyzelf (rivastigmine twice weekly) / Luye Group
NCT05853341: Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)

Completed
1
48
Europe
RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h
Luye Pharma Group Ltd., SocraTec R&D GmbH, SocraMetrics GmbH
Healthy
07/23
07/23
genakumab (Gensci048) / GeneScience
NCT05983445: Safety & Efffficacy of Genakumab in Patients With Frequent Flares

Completed
3
313
RoW
genakumab, • Gensci048, placebo for Diprospan, placebo for genakumab, Diprospan
Changchun GeneScience Pharmaceutical Co., Ltd.
Acute Gout Arthritis
04/24
04/24
Gensci 048-202, NCT05936281: A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)

Completed
2
165
RoW
Genakumab for injection, Colchicine
Changchun GeneScience Pharmaceutical Co., Ltd., Huashan Hospital
Gout, Gout Initiating Urate-loweringUrate-lowering Therapy
01/24
01/24
Gensci 048-203, NCT05936268: Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare

Completed
2
106
RoW
Genakumab for injection, Colchicine
Changchun GeneScience Pharmaceutical Co., Ltd., Huashan Hospital
Acute Gout, Gout Flare
02/24
02/24
NCT06189495: A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Recruiting
2
30
RoW
GenSci048, GenSci048 placebo
Changchun GeneScience Pharmaceutical Co., Ltd., West China Hospital
Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
03/26
10/26
NCT05328531: Clinical Study of Genakumab for Injection in Patients With Acute Gout

Completed
1/2
121
RoW
Genakumab for Injection, Placebo for Genakumab for Injection
Changchun GeneScience Pharmaceutical Co., Ltd., Huashan Hospital, Hainan General Hospital, Linyi People's Hospital, The Second Affiliated Hospital of Chongqing Medical University, Changhai Hospital, The First Affiliated Hospital with Nanjing Medical University, Shengjing Hospital, Affiliated Hospital of Nantong University
Acute Gout
06/22
06/22
NCT05894148: Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults

Completed
1
24
RoW
Genakumab injection, placebo
Changchun GeneScience Pharmaceutical Co., Ltd., Affiliated Hospital of North Sichuan Medical College
Interstitial Lung Disease
11/23
11/23
NCT05441046: Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors

Recruiting
1
120
RoW
Genakumab, Tislelizumab
GeneScience Pharmaceuticals Co., Ltd.
Malignant Solid Tumors
06/24
03/25
NCT06451848: A Bioequivalence Study of Two Different Dosage Form of Genakumab

Completed
1
178
RoW
Genakumab Injection (T, Solution for injection), Genakumab for Injection (R, Powder for solution for injection)
Changchun GeneScience Pharmaceutical Co., Ltd.
Gouty Arthritis (GA)
11/24
01/25
NCT05925452: To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

Recruiting
N/A
221
RoW
GenaKumab
Changchun GeneScience Pharmaceutical Co., Ltd.
Active Systemic Juvenile Idiopathic Arthritis
03/28
06/28
gentulizumab / GeneScience
NCT05221385: Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma

Terminated
1
58
RoW
Gentulizumab
Changchun GeneScience Pharmaceutical Co., Ltd.
Solid Tumor, Non-Hodgkin Lymphoma
05/23
10/23
NCT05263271: Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Recruiting
1
58
RoW
Gentulizumab
GeneScience Pharmaceuticals Co., Ltd., Ruijin Hospital, Shanghai Tong Ren Hospital, First Affiliated Hospital of Zhejiang University
Acute Myelogenous Leukemia, Myelodysplastic Syndromes
07/24
07/24
gentuximab / GeneScience
NCT05919381: Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.

Recruiting
3
752
RoW
Gentuximab Injection, Gentuximab Injection Placebo
GeneScience Pharmaceuticals Co., Ltd.
Adenocarcinoma of Stomach
12/24
01/25
NCT05223595: A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC

Recruiting
1
42
RoW
Gentuximab, Almonertinib
GeneScience Pharmaceuticals Co., Ltd.
Metastatic Non-Small Cell Lung Cancer
09/23
01/24
Genfulin (molgramostim topical gel) / GeneScience
No trials found

Download Options